Clinical Trial

Prognosis of Veno-Venous Extracorporeal Membrane Oxygenation in Emergency Thoracic Surgery

Study acronym: PECUR

Recruiting

Record status

This record was last updated June 13, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.

Summary

Veno-vneous extracorporeal membrane oxygenation (VV-ECMO) is an established support strategy for acute respiratory failure, but its role in the perioperative management of emergency thoracic surgery remains poorly defined. This retrospective, multicenter, observational study aims to assess the clinical outcomes and prognostic factors in this high-risk population. Patients undergoing emergency thoracic procedures requiring VV-ECMO will be compared to a control cohort of patients treated with VV-ECMO for medical respiratory failure. Data will be collected from two French academic centers (CHU Amiens-Picardie and CHU Dijon).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-05.

Status change: Not Yet Recruiting → Recruiting 2025-06-12

Trial Details

NCT Number	NCT07016685
Lead Sponsor	Centre Hospitalier Universitaire, Amiens Collaborators: Centre Hospitalier Universitaire Dijon
Conditions	VV-ECMO, Thoracic Surgery, Emergency Surgery, ARDS, Retrospective Cohort, Propensity Score Matching, Mortality, ECMO Outcomes
Enrollment	380 participants
Start Date	2025-06-01
Primary Completion	2025-11 (estimated)
Study Completion	2026-04 (estimated)
Updated on ClinicalTrials.gov	2025-06-13